BerGenBio scoops Galapagos' Heidi Pavliska
This article was originally published in Scrip
BerGenBio, an emerging oncology biopharma company, has appointed Heidi Pavliska to its board of directors. Mrs Pavliska was one of the original group of scientists who started up Galapagos. She was instrumental in the development of the company's target discovery platform and later its commercialisation across Europe. More recently, Mrs Pavliska was director of business development with AMRI.